- 4D Velocity Mapping of the Heart in rTOF Patients
- ALTERRA Post-Approval Study
- Analysis of RV-Dysfunction in Fallot Patients
- Assessment of Right Ventricular Volume in Tetralogy of Fallott (TOF) Patients
- Asynchrony in Operated Tetralogy of Fallot
- Beta-blocker Administration for Cardiomyocyte Division
- Biomodel in Tetralogy of Fallot
- Cardiac Function Under Stress for Early Detection of the Right Ventricular Insufficiency After Repair of Tetralogy of Fallot
- Comparison of Mid-term Results of Total Correction of TOF Between Preservation of PV and Trans-annular Patch.
- Comparison of RVOT Gradient Under Anaesthesia With Post-operative Gradient in Patients Undergoing TOF Repair
- Comparison of Two Pulmonary Valve Replacement Methods to Treat Tetralogy of Fallot
- Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in Repaired Tetralogy of Fallot
- Early Revalvulation After Fallot Repair Improves Clinical Outcome
- Early Versus Later Re-valving in Tetralogy of Fallot With Free Pulmonary Regurgitation
- Effect of Contouring Techniques on CMR Assessment of the Right Ventricle in Repaired Tetraology of Fallot
- Effects of Changes in Fluid Status on Right Ventricular Volumes and Function
- Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot
- Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot
- Examining Developmental Changes in Heart Contractions of Children With Congenital Heart Defects
- Exercise Training in Adults With Corrected Tetralogy of Fallot
- Exercise Training Strategies for Children With Repaired Tetralogy of Fallot
- Harmony TPV Post-Approval Study
- Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
- Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p
- Myocardial FIbrosis in Repaired Tetralogy of FAllot- FIFA Study)
- Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot
- Pediatric REPlAcement of the PulmonaRy ValvE in Tetralogy of Fallot –
- Physical Capacity and Activity in Children With Congenital Heart Disease
- Predictive Factors of Right Ventricular Function Early After Repair of Tetralogy of Fallot
- Reoxygenation for Cyanotic Pediatric CHD
- Retrospective Review of Anesthetic Considerations for Pulmonary Artery Rehabilitation
- Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System
- Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)
- The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
- The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot
- Understanding Dexmedetomidine in Neonates After Open Heart Surgery
Clinical Trials
- Biomarkers of CASH
- CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
- CCM Blood Biomarker Validation Study
- CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study
- Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
- Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)
- Modifiers of Disease Severity in Cerebral Cavernous Malformations
- Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
- The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
- Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina.
- Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
- Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment
- Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
- Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]
- Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal “Pancreatitis” Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies
- A Diagnostic Test for Familial Mediterranean Fever
- A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)
- Central Sensitization in Familial Mediterranean Fever (FMF)
- Characterization of a Functional Test for Mediterranean Family Fever Screening – 2
- Clinical and Molecular Evaluation of Childern With Familial Meditterranean Fever and Their Siblings
- Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation
- Effects of Online Aerobic Exercise Training and Physical Activity Counseling in Juvenile Familial Mediterranean Fever
- Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever
- Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
- Heat Intolerance in the Group of FMF Patients
- Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission
- Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients
- Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients
- Rilonacept for Treatment of Familial Mediterranean Fever (FMF)
- Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
- Study of Colchicine Resistance in Familial Mediterranean Fever
- Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
- The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF
- The Effect of Probiotics on Response to Therapy and on Adverse Effect in Patients Treated With Colchicine for Familial Mediterranean Fever.
- Tocilizumab for the Treatment of Familial Mediterranean Fever
- Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
- Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
- Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)
- Expansion to Interdisciplinary HIV Prevention in Women
- Fetal Alcohol Damage Prevention Study
- Fetal Alcohol Syndrome: Socio-Cognitive Habilitation
- Fetal Alcohol Syndrome/ARND Research Consortion
- Healthy Moms Alcohol Intervention
- In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
- Multisensorial Analysis of Human Activity for Diagnosis and Early Detection of Functional Limitations
- Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)
- Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)
- Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
- Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
- Prenatal Alcohol Biomarker Study in Uruguay
- RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure
- Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy
- The Oklahoma Parent-Child Assistance Program
- Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume
- Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight
- DAME: Induction of Labor or Waiting for Suspicion Fetal Macrosomia
- Fetal Front-abdominal Wall Thickness and Perinatal Outcome
- Fish Oil Supplementation in Women With Gestational Diabetes
- Gut Microbiota, SCFAs and Glucolipid Metabolism in Pregnant Women With Abnormal Fetal Size and Their Newborns
- Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia
- Regulation Of Maternal Fuel Supply And Neonatal Adiposity
- Treatment of Impaired Glucose Tolerance in Pregnancy
- A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
- Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
- Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
- KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)
- Registry to Collect Health Information Related to Fibrolamellar Cancer
- Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
- Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
- Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma